inDrive Delivery witnesses a 1.5 times increase in orders compared to the previous year on Valentine’s Day
NEW DELHI, Feb. 20, 2025 /PRNewswire/ -- Valentine's Day has slowly evolved…
Bristol Myers Squibb Presents Results from CheckMate -8HW Analysis Evaluating Opdivo (nivolumab) plus Yervoy (ipilimumab) Compared to Opdivo Monotherapy…
Patients experienced a 38% reduction in the risk of disease progression or…
Data Published Today in the New England Journal of Medicine Demonstrates Anthos Therapeutics novel Factor XI inhibitor, Abelacimab 150mg, Reduced Major or Clinically Relevant Non-Major Bleeding by 62% Compared to Rivaroxaban (Xarelto) in Patients with Atr
January 22, 2025 17:00 ET | Source: Anthos Therapeutics Secondary endpoints also…
Meta-analysis published in Annals of Surgery shows benefits of da Vinci surgery across seven oncologic procedures compared to laparoscopic and open
Analysis included 230 studies—a mix of randomized, prospective, and database research SUNNYVALE,…
Firms are optimistic about EXIM freight compared to domestic freight transported through railways- Dun & Bradstreet IRFA Report
MUMBAI, India, Nov. 26, 2024 /PRNewswire/ -- Dun & Bradstreet, a global leader…
Anthos Therapeutics Shares New Analysis from the Landmark AZALEA-TIMI 71 Study Demonstrating the Factor XI Inhibitor Abelacimab Substantially Reduced Bleeding in Patients on Antiplatelet Therapy Compared to Rivaroxaban
November 16, 2024 16:38 ET | Source: Anthos Therapeutics Data presented at…